Home / Health / US Missionary Fights Rare Ebola Strain in Germany
US Missionary Fights Rare Ebola Strain in Germany
3 Jun
Summary
- US missionary with rare Ebola strain treated in Germany.
- Experimental drugs, including obeldesivir, show promise.
- Antibody cocktail MBP134 targets multiple Ebola species.
A U.S. missionary, identified as Dr. Peter Stafford, is undergoing treatment in a German hospital for a rare Bundibugyo strain of Ebola. This outbreak in the Democratic Republic of Congo has infected nearly 750 people and resulted in 177 fatalities. Health officials are providing symptom-reducing drugs and other therapies to the patient, though specific treatments remain confidential.
The World Health Organization has declared the outbreak an international emergency. Gilead Sciences' experimental antiviral pill, obeldesivir, is considered a promising option. While not tested on the current outbreak strain in humans, it has shown efficacy against other Ebola species and related viruses in animal studies.
Another potential treatment is the experimental antibody cocktail MBP134. This therapy, developed from antibodies of an Ebola survivor, is designed to target multiple Ebola species, including Bundibugyo. Animal trials indicate it can protect against lethal disease even when administered after symptoms appear, making it a strong candidate for this outbreak.
